1. Home
  2. CTAS vs BMY Comparison

CTAS vs BMY Comparison

Compare CTAS & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTAS
  • BMY
  • Stock Information
  • Founded
  • CTAS 1968
  • BMY 1887
  • Country
  • CTAS United States
  • BMY United States
  • Employees
  • CTAS N/A
  • BMY N/A
  • Industry
  • CTAS Business Services
  • BMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTAS Consumer Discretionary
  • BMY Health Care
  • Exchange
  • CTAS Nasdaq
  • BMY Nasdaq
  • Market Cap
  • CTAS 85.4B
  • BMY 94.0B
  • IPO Year
  • CTAS N/A
  • BMY N/A
  • Fundamental
  • Price
  • CTAS $199.51
  • BMY $45.57
  • Analyst Decision
  • CTAS Buy
  • BMY Hold
  • Analyst Count
  • CTAS 13
  • BMY 15
  • Target Price
  • CTAS $227.08
  • BMY $57.64
  • AVG Volume (30 Days)
  • CTAS 2.0M
  • BMY 10.4M
  • Earning Date
  • CTAS 09-24-2025
  • BMY 10-30-2025
  • Dividend Yield
  • CTAS 0.90%
  • BMY 5.44%
  • EPS Growth
  • CTAS 16.09
  • BMY N/A
  • EPS
  • CTAS 4.40
  • BMY 2.49
  • Revenue
  • CTAS $10,340,181,000.00
  • BMY $47,704,000,000.00
  • Revenue This Year
  • CTAS $9.62
  • BMY N/A
  • Revenue Next Year
  • CTAS $7.14
  • BMY N/A
  • P/E Ratio
  • CTAS $45.34
  • BMY $18.33
  • Revenue Growth
  • CTAS 7.75
  • BMY 2.57
  • 52 Week Low
  • CTAS $180.78
  • BMY $42.96
  • 52 Week High
  • CTAS $229.24
  • BMY $63.33
  • Technical
  • Relative Strength Index (RSI)
  • CTAS 30.90
  • BMY 39.05
  • Support Level
  • CTAS $198.01
  • BMY $46.00
  • Resistance Level
  • CTAS $202.90
  • BMY $46.84
  • Average True Range (ATR)
  • CTAS 3.03
  • BMY 0.92
  • MACD
  • CTAS -0.28
  • BMY -0.17
  • Stochastic Oscillator
  • CTAS 12.29
  • BMY 1.84

About CTAS Cintas Corporation

Cintas has roots tracing back to 1929, during which the Farmer family cleaned and re-sold dirty rags to manufacturing plants in Ohio. The firm has grown its business organically and through acquisitions, and today Cintas acts as a one-stop outsourcing partner for businesses. Cintas will design, manufacture, collect, and clean every employee uniform for a small weekly sum, taking on the upfront capital expense itself. In the same stop, Cintas can also replace soiled or depleted mats, mops, trash liners, towels, first aid, fire, and cleaning products. Businesses value an outsourcing partner like Cintas as it simplifies operations and leaves noncore tasks with high regulatory standards in the hands of professionals.

About BMY Bristol-Myers Squibb Company

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Share on Social Networks: